Background: Increasing evidence suggests that the inability to undergo apoptosis is an important factor in the development and progression of prostate cancer. Agents that induce apoptosis may inhibit tumor growth and provide therapeutic benefit. In a recent study, the authors found that certain homeopathic treatments produced anticancer effects in an animal model. In this study, the authors examined the immunomodulating and apoptotic effects of these remedies. Materials and Methods: The authors investigated the effect of a homeopathic treatment regimen containing Conium maculatum, Sabal serrulata, Thuja occidentalis, and a MAT-LyLu Carcinosin nosode on the expression of cytokines and genes that regulate apoptosis. This was assessed in prostate cancer tissues, extracted from animals responsive to these drugs, using ribonuclease protection assay or reverse transcription polymerase chain reaction. Results: There were no significant changes in mRNA levels of the apoptotic genes bax, bcl-2, bcl-x, caspase-1, caspase-2, caspase-3, Fas, FasL, or the cytokines interleukin (IL)-1α, IL-1β, tumor necrosis factor (TNF)-β, IL-3, IL-4, IL-5, IL-6, IL-10, TNF-α, IL-2, and interferon-γ in prostate tumor and lung metastasis after treatment with homeopathic medicines. Conclusions: This study indicates that treatment with the highly diluted homeopathic remedies does not alter the gene expression in primary prostate tumors or in lung metastasis. The therapeutic effect of homeopathic treatments observed in the in vivo experiments cannot be explained by mechanisms based on distinct alterations in gene expression related to apoptosis or cytokines. Future research should explore subtle modulations in the expression of multiple genes in different biological pathways.
Apoptosis and cell cycle progression are 2 intimately linked phenomena. The ability of tumor cells to respond to damage and eventually activate the apoptotic cascade determines the ultimate success of cancer therapy. 1 Tang and Porter 2 summarized the data on the relationship between apoptosis and prostate cancer and concluded that identification of new therapeutic agents can be achieved by analyzing apoptotic changes. The key regulators involved in apoptosis are well characterized and include caspases, Bcl-2 family, tumor necrosis factor (TNF) receptor family, and other adapter proteins. 3 Androgen-dependent prostate tumors undergo apoptosis in response to androgen ablation and expression of Bcl-2, and caspases correlate with the prostate cancer cell's sensitivity to the therapy. Prostate cancers respond to hormone ablation through apoptosis, which is regulated by several genes including the tumor suppressor gene p53 and proto-oncogene Bcl-2. 4 Bcl-2 confers negative control in the pathway of cellular suicide machinery. A Bcl-2 homologous protein, Bax, promotes cell death by competing with Bcl-2. While Bax-Bax homodimers act as apoptosis inducers, Bcl-2-Bax heterodimer formation evokes a survival signal for the cells. Both Bcl-2 and Bax are transcriptional targets for the tumor suppressor protein, p53, which induces cell cycle arrest or apoptosis in response to DNA damage. Thus, evaluation of novel therapies such as those in complementary and alternative medicine should examine these factors as possible mechanisms.
In a previous study conducted in our laboratory, we investigated the antitumor effect of a homeopathic treatment comprising Conium maculatum, Thuja occidentalis, Sabal serrulata, and homeopathic Carcinosin on the prostate cancer line MAT-LyLu cells growth in Copenhagen rats. We found significant reduction in the tumor incidence (23%), tumor volume (45%), and tumor weight (33%) in the homeopathy-treated group as compared with the control group. The study also revealed increased apoptosis and decreased 
proliferation in MAT-LyLu cells inoculated into
Copenhagen rats in comparison to untreated controls. 5 In the present study, we have analyzed the effect of homeopathic treatment on the expression of genes involved in apoptosis and cytokines in tumor and lung tissues from the homeopathy-treated animals to explore possible mechanisms underlying homeopathic treatment. A few available studies have suggested immunoregulation by homeopathy in high dilutions. 6
Materials and Methods

Homeopathic Medicines
Homeopathic medicines C maculatum, S serrulata, T occidentalis, Asterias, and Phytolacca with 30 c, 200 c, and 1000 c concentrations were obtained from Boiron (Simi Valley, Calif). Carcinosins (1000 c) were prepared from MAT-LyLu and MDA-MB-231 cells by Washington Homeopathic Products Inc (Bethesda, Md), as previously described. 7
Animal Treatment and Tissue Collection
Tissues collected from the animals, in our in vivo study with Copenhagen rats described earlier, 7 were used in the present study. Briefly, Copenhagen rats inoculated with MAT-LyLu cells were fed with 100 µL of a homeopathic remedy regimen or succussed water as controls once daily. The homeopathic treatment regimen contained T occidentalis (100 c) on the first and fourth day of the week, C maculatum (1000 c) on the second and fifth day of the week, S serrulata (200 c) on the third and sixth day of the week, and MAT-LyLu Carcinosin (1000 c) on the seventh day of the week. Five weeks after cell inoculation, the experiment was concluded and animals were killed. At the time of killing, tumors and lungs were removed, weighed, and immediately frozen for further analysis.
mRNA Analysis by Ribonuclease Protection Assay
To determine the effect of homeopathic treatment on mRNA expression, tumor and lung tissue specimens were homogenized, and the total RNA was isolated using TRIzol (Invitrogen, Carlsbad, Calif). The isolated RNA was quantitated by spectrophotometry and equalized, and the purity was checked on 1% formaldehyde agarose gel. mRNA expression of treated and untreated cells was determined by ribonuclease protection assay (RPA). mRNA levels for apoptotic genes and cytokines were estimated using RiboQuant multiprobe sets rAPO-1 (bax, bcl-2, bcl-x, caspase-1, caspase-2, caspase-3, Fas, FasL, L32, and glyceraldehyde 3-phosphate dehydrogenase [GAPDH]) and rCK-1 (interleukin [IL]-1α, IL-1β, TNF-β, IL-3, IL-4, IL-5, IL-6, IL-10, TNF-α, IL-2, interferon [IFN]-γ, L-32, and GAPDH) using a kit from BD Biosciences (San Diego, Calif), respectively. The protocols used for the RPA were according to the manufacturer's instructions. Briefly, 20 µg of each RNA sample was hybridized at 56°C for 12 to 14 hours with a 32 P-UTP-labeled probe. The probe was prepared by transcribing the rat apoptosis template set using T7 RNA polymerase. After hybridization, samples were subjected to RNase digestion for 45 minutes at 30°C. The ribonuclease-protected bands were then resolved on denaturing urea-polyacrylamide gels, followed by autoradiography. L32 and GAPDH mRNAs served as housekeeping gene controls in the assay to ensure equal loading of RNAs.
mRNA Estimations by Reverse Transcriptase Polymerase Chain Reaction From Laser-Controlled Microdissected Tumor Tissue From Lung Specimens
We also performed mRNA analysis based on lasercontrolled microdissection (LCM) of defined regions of the tissues. The LCM technique allowed for efficient isolation of tumor regions with no or very low contamination of surrounding tissue components, simultaneously leaving the intracellular structure and molecules intact. Frozen lung tissue specimens from animal experiments 7 were used for LCM using the Arcturus PixCell IIe Laser Capture Microdissection System and the Histogene LCM Frozen Section Staining Kit (Arcturus, Mountain View, Calif). Total RNA was isolated from microdissected regions using the PicoPure RNA Isolation Kit (Arcturus, Mountain View, Calif). Complementary DNA was synthesized using total RNA and the SuperScript First Strand Synthesis System for reverse transcriptase polymerase chain reaction (RT-PCR; Invitrogen, Carlsbad, Calif). Primers for caspase-1 and GAPDH were obtained from Maxim Biotech Inc (South San Francisco, Calif). Caspase-3 primers were synthesized 5′ ACG GTA CGC GAA GAA AAG TGA C 3′ for sense and 5′ TCC TGA CTT CGT ATT TCA GGG C 3′ for antisense. The PCR reaction mixture contained 10 pmol/L of each primer pair and 2.5 U of Taq DNA polymerase (Invitrogen, Carlsbad, Calif). The linear range of amplification of each gene was determined by carrying out 18 to 35 cycles in increments of 3 cycles each. Based on the results, amplification reactions were carried out in 25 to 33 customized cycles for each gene (95°C for 30 seconds, 55°C-60°C for 45 seconds, and 72°C for 60 seconds) using 10% of cDNA. Annealing temperatures used were 3°C to 5°C less than the primer's melting temperature. GAPDH was used as an internal control. PCR products (10 µL each) were analyzed by electrophoresis on 2% agarose gels containing ethidium bromide. Densitometric analysis of PCR products was performed with Scanalyze software, and the quantitations were normalized to GAPDH.
Results
Effect of Homeopathic Treatment on Apoptotic Gene Expression in Tumor Tissues
MAT-LyLu cells inoculated in rats treated with the different homeopathic medicines, C maculatum, MAT-LyLu Carcinosin, S serrulata, and T occidentalis were analyzed for modulations in gene expression and were compared with the untreated controls. The study was done by RPA specifically for genes involved in the apoptotic process. The analysis with the multiprobe set for apoptosis (rAPO-1) containing Fas antigen, bclXL, bclXS, FasL, caspase-1, caspase-3, caspase-2, bax, and bcl-2 showed no significant differences in mRNA levels for any of these apoptotic genes between treated and water-treated controls in tumor and lung tissues ( Figure  1 ). However, marked differences were observed in the caspase-1 mRNA levels between lung and tumor tissue specimens. Primary tumors lacked the expression of caspase-1, whereas lung tumors and normal animal tissue showed caspase-1 expression. Homeopathy treatment did not alter the expression of this gene.
As gene expression analysis using total RNA of bulk tissue did not show specific differences in the gene expression of homeopathy-treated and water-treated tissues, we extended the analysis to LCM-captured lung tumor tissue that facilitates elimination of skewed data from contamination of tumor tissue with surrounding normal tissue. Expression analysis for the apoptotic genes caspase-1 and caspase-3 from such microdissected tissue also did not show any significant differences between homeopathy-treated and watertreated lung tumor specimens ( Figure 2 ).
Effect of Homeopathic Medicines on Inflammatory Cytokines
We investigated the cytokine profiles in the lungs and tumors of Copenhagen rats inoculated with MAT-LyLu cells and treated with the homeopathic treatment regimen. The analysis was done by RPA using a multiprobe panel (rCK-1) having IL-1α, IL-1β, TNF-β, IL-3, IL-4, IL-5, IL-6, IL-10, TNF-α, IL-2, and IFN-γ. No significant differences were observed for any of the cytokines analyzed between homeopathy-treated and water-treated controls (Figure 3 ). L-32 and GAPDH mRNAs served as housekeeping gene controls in the assay to normalize the data for equalizing the RNAs.
Discussion
Homeopathy is one of the most widely used complementary and alternative medicines in the world, 8 and many consider it as a placebo treatment because of the extremely low doses used. 9 The physical nature of homeopathic remedies and also the precise role of succussion in the remedy preparation process are unknown. However, evidence presented in our previous study indicates effectiveness of homeopathic medicines in reducing tumor incidence, tumor growth, and metastasis in rats. 7 Given these observations, we explored possible mechanisms for these effects by investigating the regulation of apoptotic genes and cytokines in the prostate tumors of Copenhagen rats that responded to homeopathy. Studies from several independent laboratories have also indicated enhanced cellular adaptive process and anticancer effects with low doses of chemicals including some homeopathy medicines. [10] [11] [12] Similarly, ultralow doses of cadmium have been shown to induce the expression of protective proteins 13 and render the protection of prostate cells from neoplastic transformation to higher dose exposures. 14 Arsenic trioxide has been widely used in homeopathic medicine and has been shown to induce incomplete differentiation, apoptosis, and degradation of oncogenic protein in acute promyeloycytic leukemia. [15] [16] [17] Ultralow doses of TNF and adriamycin/cisplatinum have been reported to induce apoptosis in resistant human ovarian cancer cells. 18 Immunotherapy of hepatocellular carcinoma patients using an ultralow dose of IL-2 (1 MIU/d) induced tumor regression and prolonged the patients' survival. 19 Recently, the toxicity of ultrahigh dilutions of 3,5-dichlorophenol showed a significant inhibitory effect from these preparations using luminescent bacteria testing. 20 Analyses of reports from clinical trials of homeopathy have been mixed. 9, 21 While these studies address the clinical effects of homeopathic medicines, they do not address mechanisms of action.
Treatment with high dilutions in our study did not show any significant effect on the expression of genes analyzed. In a separate study, treatment of human as well as rat prostate cells with highly diluted homeopathic medicines also did not show any alterations in their mRNA expression. 22 During prostate tumorigenesis, losses in the protein expression of apoptotic genes such as caspase-1 and caspase-3 have been reported. 23 In the same study, RT-PCR analysis of mRNA expression did not show reduced expression in all the specimens analyzed, suggesting posttranscriptional deregulation. However, in our study, we found a reduction in the mRNA expression of caspase-1 only in all primary tumor tissues and not in lung tissues. The discrepancy in the expression between primary tumors and lung tumors may indicate tissue-specific differences and probably different mechanisms involved in the caspase-1 regulation. Also, homeopathic medicines did not alter caspase-1 expression in either of these tissues.
Conclusions
In conclusion, our experiments show that the investigation of specific gene expression analysis for apoptosis and cytokine alteration may not provide sufficient insights into the mechanisms of homeopathic treatment of prostate cancer. Investigation of the homeopathic treatment of cancer may require novel and sensitive methodologies such as global gene array analysis to detect subtle differences to account for the beneficial effects of homeopathic treatment in vivo. We are planning to study the changes in protein levels using proteomics in the future.
